All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YF223 | Human anti-QGSP T cell receptor (578.45), pCDTCR1 | Triticum aestivum | 578.45 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF224 | Human anti-QGSP T cell receptor (578.51), pCDTCR1 | Triticum aestivum | 578.51 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF225 | Human anti-QGSP T cell receptor (578.59), pCDTCR1 | Triticum aestivum | 578.59 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF226 | Human anti-QGSP T cell receptor (737.16), pCDTCR1 | Triticum aestivum | 737.16 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF227 | Human anti-QGSP T cell receptor (737.2), pCDTCR1 | Triticum aestivum | 737.2 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF228 | Human anti-QGSP T cell receptor (737.26), pCDTCR1 | Triticum aestivum | 737.26 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF229 | Human anti-QGSP T cell receptor (737.3), pCDTCR1 | Triticum aestivum | 737.3 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF230 | Human anti-QGSP T cell receptor (737.7), pCDTCR1 | Triticum aestivum | 737.7 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF231 | Human anti-QGSP T cell receptor (TCC737.A4B30), pCDTCR1 | Triticum aestivum | TCC737.A4B30 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector | |
TCR-YF232 | Human anti-QGSP T cell receptor (TCC774.A4B9), pCDTCR1 | Triticum aestivum | TCC774.A4B9 | Human | FPQPQQPFPWQP + DEAM(Q5) | HLA-DQA1*05:01/DQB1*02:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION